Israel Discount Bank of New York’s Impax Laboratories, Inc. IPXL Stock Holding History

Israel Discount Bank of New York’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,780	Closed	-$35K	–	416
2018 Q1	$35K	Hold	1,780	–	–	0.02%	335
2017 Q4	$30K	Buy	1,780 +870	+96%	+$15.9K	0.02%	356
2017 Q3	$18K	Hold	910	–	–	0.01%	374
2017 Q2	$15K	Sell	910 -20	-2%	-$295	0.01%	378
2017 Q1	$12K	Sell	930 -25	-3%	-$302	0.01%	394
2016 Q4	$13K	Buy	+955	New	+$16.3K	0.01%	419

Israel Discount Bank of New York's IPXL Position: Q2 2018 in Review

Israel Discount Bank of New York sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,780 shares — an estimated $35K sold.

Israel Discount Bank of New York first reported a position in IPXL in Q4 2016 and held it in 6 quarters. The position peaked at $35K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

Israel Discount Bank of New York reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
Israel Discount Bank of New York sold 1,780 Impax Laboratories, Inc. shares in Q2 2018, an estimated $35K.
Israel Discount Bank of New York first reported a position in Impax Laboratories, Inc. in Q4 2016 and held it in 6 quarters.
Israel Discount Bank of New York's Impax Laboratories, Inc. position peaked at $35K in Q1 2018.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Israel Discount Bank of New York's 13F filing for Q2 2018, filed 1 Aug 2018.